Treatment of Langerhans Cell Histiocytosis With Pamidronate
- 1 January 2001
- journal article
- case report
- Published by Wolters Kluwer Health in Journal of Pediatric Hematology/Oncology
- Vol. 23 (1) , 54-56
- https://doi.org/10.1097/00043426-200101000-00013
Abstract
A 14-year-old boy with longstanding multisystem Langerhans cell histiocytosis (LCH) had multifocal bone pain unresponsive to chemotherapy, corticosteroids, anti-inflammatories, and narcotic analgesics. He responded to two cycles of intravenous pamidronate, each 90 mg per day on three consecutive days. Two subsequent episodes of deterioration also responded to treatment. The pathophysiology of his bone pain and the likely mechanisms of biphosphonate action are discussed, with emphasis on the molecular and cellular basis of LCH.Keywords
This publication has 16 references indexed in Scilit:
- Loss of FancC Function Results in Decreased Hematopoietic Stem Cell Repopulating AbilityBlood, 1999
- Effect of a Short-Term Treatment with Alendronate on Bone Density and Bone Markers in Patients with Central Diabetes InsipidusJournal of Clinical Endocrinology & Metabolism, 1999
- Use of indomethacin in Langerhans cell histiocytosisMedical and Pediatric Oncology, 1999
- Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitroProceedings of the National Academy of Sciences, 1999
- Macrophage Depletion by Albumin Microencapsulated Clodronate: Attenuation of Cytokine Release in Macrophage-Dependent GlomerulonephritisDrug Development and Industrial Pharmacy, 1999
- Long‐term oral pamidronate treatment inhibits osteoclastic bone resorption and bone turnover without affecting osteoblastic function in multiple myelomaEuropean Journal of Haematology, 1998
- Malignant bone pain: pathophysiology and treatmentPain, 1997
- A multicentre retrospective survey of Langerhans' cell histiocytosis: 348 cases observed between 1983 and 1993. The French Langerhans' Cell Histiocytosis Study Group.Archives of Disease in Childhood, 1996
- Bisphosphonates act on osteoblastic cells and inhibit osteoclast formation in mouse marrow culturesBone, 1996
- Histiocytosis X. Purified (T6+) cells from bone granuloma produce interleukin 1 and prostaglandin E2 in culture.Journal of Clinical Investigation, 1986